Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Mar 14, 2008; 14(10): 1603-1611
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1603
Figure 1
Figure 1 Survival rates of patients with pancreatic cancer. A: Overall results and those in patients with different location and size of the tumor; B: Pancreatic cancer with different modes of therapies, and with or without hepatic metastases.
Figure 2
Figure 2 Pancreatic CT scan in case 1. A: Before treatment; B: Three months after treatment; C: Twelve months after treatment.
Figure 3
Figure 3 CT scan of case 2. A: Before treatment, a mass was seen in pancreatic body and trail; B: 0ne month after treatment; C: Six months after treatment.
Figure 4
Figure 4 CT scan in case 3. A: One months after treatment; B: Three months after treatment.
Figure 5
Figure 5 CT scan in case 4. A: Before treatment; B: Eight months after treatment.
Figure 6
Figure 6 CT scan in case 5. A and B showing cryoprobe and 125iodine seeds in different layers during treatment.
Figure 7
Figure 7 CT and PET-CT in case 6. A: CT at 10 mo after the first treatment, showing 125iodine seeds; B: PET-CT at 12 mo after the first treatment showing new lesion in pancreatic body; C: PET-CT at 3 mo after second treatment.